Treatment with Vitamin K Antagonists: Frequency of Indications and Appropriateness of Continuation

Publisher： Karger

E-ISSN： 1424-8840|32|3|111-114

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.32, Iss.3, 2002-10, pp. : 111-114

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

For How Long Should the Treatment with Vitamin K Antagonists Be Maintained?

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 29, Iss. 1, 2004-11 ,pp. : 89-90

Karger

Access to resources Recommend Favorite

Early versus Delayed Introduction of Oral Vitamin K Antagonists in Combination with Low-Molecular-Weight Heparin in the Treatment of Deep Vein Thrombosis

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 2, 1999-03 ,pp. : 70-77

Karger

Access to resources Recommend Favorite

Clinical impact and course of major bleeding with rivaroxaban and vitamin K antagonists

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 9, 2015-09 ,pp. : 1590-1596

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reversal strategies for vitamin K antagonists in acute intracerebral hemorrhage

By  

ANNALS OF NEUROLOGY, Vol. 78, Iss. 1, 2015-07 ,pp. : 54-62

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of Vitamin K Antagonists and Brain Volumetry in Older Adults: Preliminary Results From the GAIT Study

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 63, Iss. 10, 2015-10 ,pp. : 2199-2202

John Wiley & Sons Inc

Access to resources Recommend Favorite